Address & contact
https://nrc.gov.ae/Specialties
Reports that name this provider
- Ibogaine Treatment Legality in United Arab Emirates
- operates with abstinence-based and evidence-based behavioral programs including CBT, the Matrix Model, and 12-step facilitation; does not offer psychedelic-assisted therapies
- Medical Detox Quality in United Arab Emirates
- WHO Collaborative Centre (since 2017), CARF-accredited (2024), UN accreditation for substance-use testing laboratories. 169-bed facility (expanded from 90 beds in 2022-2023). Mean inpatient detox stay of five days. Psychiatrist-led multidisciplinary teams. Introduced buprenorphine opioid-assisted treatment in 2003, first in the Arab world. Laboratory services integrated into care.
- Psychedelic Treatment Quality in United Arab Emirates
- Established in 2002, partnered with McLean Harvard Hospital and the Matrix Institute on Addictions
- Residential Rehab Quality in United Arab Emirates
- Founded 2002. WHO Collaborating Centre since 2017. CARF International 3-year accreditation January 2025 covering inpatient, outpatient, and detoxification programs. Expanded from 18 beds (2002) to 169 beds by 2016; 40-patient/day outpatient capacity. Treatment teams led by psychiatrists trained with King's College London and UAE University in Matrix Programme interventions. Introduced buprenorphine in 2003 (first in region). Relapse rate improved from 60% (2003) to 20% (2010). 73% of 632 new patients admitted voluntarily; patient satisfaction above 75%. Accepts expatriates since January 2017. Two-year aftercare follow-up.